BiotechTubeBiotechTube
Home/Celldex Therapeutics/Sam Martin
SM

Sam Martin

Chief Financial Officer and Senior Vice President

Celldex Therapeutics

Therapeutic Areas

OncologyImmunologyInflammatory Diseases

Celldex Therapeutics Pipeline

DrugIndicationPhase
Barzolvolimab (CDX-0159)Chronic Spontaneous Urticaria (CSU)Phase 2b
CDX-1149Solid TumorsPhase 1
CDX-585Solid TumorsPhase 1

Leadership Team at Celldex Therapeutics

AS
Anthony S. Marucci
Co-founder, President and Chief Executive Officer
DC
Diane C. Young, M.D.
Senior Vice President and Chief Medical Officer
RT
Richard T. Kenney, M.D.
Vice President, Clinical Development
BC
Boris C. Pasche, M.D., Ph.D., FACP
Chairman of the Board of Directors
JJ
James J. Egan, Ph.D.
Director
GA
Garry A. Neil, M.D.
Director
MJ
Martha J. Demski
Director
FW
Frederick W. Driscoll
Director
MR
Michael R. Dougherty
Director
AM
Anne M. Phillips, M.D.
Director
View full Celldex Therapeutics profile